Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Hodgkin lymphoma: Current and future therapeutic strategies].
Turpin A, Michot JM, Kempf E, Mazeron R, Dartigues P, Terroir M, Boros A, Bonnetier S, Castilla-Llorente C, Coman T, Danu A, Ghez D, Pilorge S, Arfi-Rouche J, Dercle L, Soria JC, Carde P, Ribrag V, Fermé C, Lazarovici J. Turpin A, et al. Among authors: mazeron r. Bull Cancer. 2018 Jan;105(1):81-98. doi: 10.1016/j.bulcan.2017.11.008. Epub 2017 Dec 27. Bull Cancer. 2018. PMID: 29289336 Review. French.
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Michot JM, Mazeron R, Danu A, Lazarovici J, Ghez D, Antosikova A, Willekens C, Chamseddine AN, Minard V, Dartigues P, Bosq J, Carde P, Koscielny S, De Botton S, Ferme C, Girinsky T, Ribrag V. Michot JM, et al. Among authors: mazeron r. Eur J Cancer. 2015 Nov;51(16):2386-95. doi: 10.1016/j.ejca.2015.07.009. Epub 2015 Aug 5. Eur J Cancer. 2015. PMID: 26254810
Brachytherapy for Conservative Treatment of Invasive Penile Carcinoma: Prognostic Factors and Long-Term Analysis of Outcome.
Escande A, Haie-Meder C, Mazeron R, Maroun P, Cavalcanti A, de Crevoisier R, Schernberg A, Marsolat F, Blanchard P, Martinetti F, Bossi A, Dumas I, Deutsch E, Chargari C. Escande A, et al. Among authors: mazeron r. Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):563-570. doi: 10.1016/j.ijrobp.2017.02.090. Epub 2017 Feb 28. Int J Radiat Oncol Biol Phys. 2017. PMID: 28501419
Clinical Experience with Pulse Dose Rate Brachytherapy for Conservative Treatment of Penile Carcinoma and Comparison with Historical Data of Low Dose Rate Brachytherapy.
Kamsu-Kom L, Bidault F, Mazeron R, Baratiny C, Martin V, Maroun P, Dumas I, Guemnie-Tafo A, Martinetti F, Gerbaulet A, Chargari C, Haie-Meder C. Kamsu-Kom L, et al. Among authors: mazeron r. Clin Oncol (R Coll Radiol). 2015 Jul;27(7):387-93. doi: 10.1016/j.clon.2015.03.010. Epub 2015 May 21. Clin Oncol (R Coll Radiol). 2015. PMID: 26003455
Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors.
Escande A, Gouy S, Mazeron R, Bentivegna E, Bacorro W, Maroun P, Schernberg A, Oberlander AS, Dumas I, Genestie C, Deutsch E, Morice P, Haie-Meder C, Chargari C. Escande A, et al. Among authors: mazeron r. Gynecol Oncol. 2017 Mar;144(3):541-546. doi: 10.1016/j.ygyno.2016.12.026. Epub 2017 Jan 15. Gynecol Oncol. 2017. PMID: 28095994
D2cm³/DICRU ratio as a surrogate of bladder hotspots localizations during image-guided adaptive brachytherapy for cervical cancer: assessment and implications in late urinary morbidity analysis.
Mazeron R, Dumas I, Rivin E, Martin V, Benhabib-Boukhelif W, Tailleur A, Guemnie-Tafo A, Martinetti F, Chargari C, Lefkopoulos D, Haie-Meder C. Mazeron R, et al. Brachytherapy. 2015 Mar-Apr;14(2):300-7. doi: 10.1016/j.brachy.2014.10.005. Epub 2014 Nov 29. Brachytherapy. 2015. PMID: 25442061
94 results